PE-060 Is Japanese Guideline of Antithrombotic Therapy Valid to Prevent Ischemic Stroke for Patients with Nonvalvular Paroxysmal Atrial Fibrillation?(PE010,Thromboembolism/Antithrombotic Therapy/Thrombolysis 1 (IHD),Poster Session (English),The 73rd Annua
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2009-03-01
著者
-
Komatsu Takashi
Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine
-
Tachibana Hideaki
Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine
-
Orii Makoto
Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine
-
Nakamura Motoyuki
Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine
-
Tsubokawa Toshinari
Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine
-
Sato Yoshihiro
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Tachibana Hideaki
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Komatsu Takashi
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Nakamura M
Department Of Internal Medicine Division Of Cardiology And Memorial Heart Center Iwate Medical Unive
-
Orii Makoto
Division Of Cardiology Department Of Internal Medicine Memorial Heart Center Iwate Medical Universit
-
Orii Makoto
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Kobayashi Takao
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Nakamura Motoyuki
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Nakamura Motoyuki
岩手医科大学 内科学講座循環器内科
-
Kobayashi Ken
Division of Cardiology, Department of Internal Medicine and Memorial Heart Center, Iwate Medical Uni
-
Ozawa Mahito
Division of Cardiology, Department of Internal Medicine and Memorial Heart Center, Iwate Medical Uni
-
Sato Yoshishiro
Division of Cardiology, Department of Internal Medicine and Memorial Heart Center
-
Tsubokawa Toshinari
Division Of Cardiovascular Medicine Kanazawa University Graduate School Of Medical Science
-
Tsubokawa Toshinari
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center
-
Ozawa Mahito
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Nakamura M
Department Of Health Promotion And Education Osaka Medical Center For Health Science And Promotion:f
-
Nakamura M
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Nakamura Motoyuki
Division Of Cardiology Department Of Internal Medicine Iwate Medical University
-
Nakamura Motoyuki
Second Department Of Medicine Iwate Medical University
-
Koeda Tatsuhiko
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical Unive
-
Koeda Tatsuhiko
Division Of Cardiology Department Od Internal Medicine Memorial Heart Center Iwate Medical Universit
-
Koeda Tatsuhiko
Division Of Cardiology Department Of Internal Medicine Memorial Heart Center Iwate Medical Universit
-
Kobayashi Ken
Division Of Cardiology Department Of Internal Medicine And Memorial Heart Center Iwate Medical University
-
Ozawa Mahito
Division of Cardio-angiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University
-
Nakamura Motoyuki
Division of Cardioangiology, Department of Internal Medicine, Iwate Medical University
-
Tachibana Hideaki
Division of Cardio-angiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University
-
KOMATSU Takashi
Division of Cardio-angiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University
-
NAKAMURA Motoyuki
Division of Cardio-angiology, Nephrology and Endocrinology, Department of Internal Medicine, Iwate Medical University
関連論文
- Relationship Between CHADS2 Score and Ischemic Stroke During Rhythm Control Therapy for Paroxysmal Atrial Fibrillation
- OE-084 Impact of Gene Mutation Regions of HERG Channel, Pore or Nonpore, on Clinical Course of LQTS(Arrhythmia, basic-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-223 A Novel Missense Mutation Met1107Thr in Cardiac Ryanodine Receptor Gene is Associated with Hypertrophic Cardiomyopathy(Cardiomyopathy, basic/clinical-2 (M) OJ38,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japa
- Standardized Prevalence Ratios for Chronic Hepatitis C Virus Infection Among Adult Japanese Hemodialysis Patients
- Plasma B-Type Natriuretic Peptide Level and Cardiovascular Events in Chronic Kidney Disease in a Community-Based Population
- Comparison of Long-Term Prognostic Evaluation Between Pre-Intervention Thrombolysis and Primary Coronary Intervention : A Prospective Randomized Trial : Five-Year Results of the IMPORTANT Study
- Low-Density Lipoprotein-Cholesterol/High-Density Lipoprotein-Cholesterol Ratio Predicts Lipid-Rich Coronary Plaque in Patients With Coronary Artery Disease : – Integrated-Backscatter Intravascular Ultrasound Study –
- Comparison of Long-Term Prognostic Evaluation Between Pre-Intervention Thrombolysis and Primary Coronary Intervention: A Prospective Randomized Trial : – Five-Year Results of the IMPORTANT Study –
- Efficacy of Antiarrhythmic Drug Therapy in Preventing Recurrence of Atrial Fibrillation and Long-Term Cardiovascular Prognosis in Patients With Asymptomatic Paroxysmal Atrial Fibrillation : Comparison to Patients With Symptomatic Atrial Fibrillation
- PJ-816 Is There Difference in Neo-intimal Hyperplasia between Drug-Eluting and Bare- Metal Stent : Optical Coherence Tomography and Integrated-Backscatter Intravascula-Ultrasound (IB-IVUS) study(PJ137,Intravascular Imagings 1 (I),Poster Session (Japanese)
- PJ-755 LDL Cholesterol/HDL Cholesterol Ratio Relate to Lipid Pool Volume in Coronary Artery Plaque IB IVUS Study(PJ127,Intravascular Imagings 2 (I),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-193 What Levels of Plasma BNP are Related to Increased Risk of Onset of Cardiovascular Events in the General Population?(PJ033,Preventive Medicine/Epidemiology/Education 1 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese
- PJ-138 Long-term Prognostic Evaluation between Pre-intervention Thrombolysis and Direct Coronary-Intervention in Acute ST-Elevation Myocardial Infarction (STEMI) Patients : A Prospective Randomized Trial(PJ023,ACS/AMI (Clinical/Pathophysiology/Treatment/B
- OJ-228 Intensive Lipid-lowering Therapy with Atorvastatin Decreases Plasma Leptin with Improving Angiogenic Factors in Patients with Coronary Artery Disease(OJ38,Atherosclerosis (Clinical/Treatment) (IHD),Oral Presentation (Japanese),The 73rd Annual Scien
- OJ-176 Prehypertension is an Indicator of High Prevalence of Albuminuria, and a Predictor of Cardiovascular Events in the General Population(OJ30,Hypertension, Clinical (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Ci
- OJ-171 Assessment of Small Size Stent Patency using 320-Slice Multidetector Computed Tomography : Comparison with Quantitative Coronary Angiography and Intravascular Ultrasound(OJ29,CT/MRI (New Technology) (I),Oral Presentation (Japanese),The 73rd Annual
- OJ-091 Is Metabolic Syndrome a Useful Predictor for Cardiovascular Events and Death in the Rural Population?(OJ16,Metabolic Syndrome (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OJ-012 Is Plasma B-type Natriuretic Peptide Measurement Valid for Prediction of Cardiovascular Events and Death in Obese Subjects?(OJ02,Obesity/SAS (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OE-262 Effects of Atrovastatin on MicroRNA-22/222 Levels and Number of Endothelial Progenitor Cells Obtained from Patients with Coronary Artery Disease(OE45,Angina Pectoris (Clinical, Basic) (IHD),Oral Presentation (English),The 73rd Annual Scientific Mee
- OE-173 Hemodialysis Patients have 7 to 20-fold Higher Mortality Risks and 11 to 31-fold Higher Incidence Rates of Acute Myocardial Infarction(OE30,Preventive Medicine/Epidemiology/Education (H),Oral Presentation (English),The 73rd Annual Scientific Meetin
- OE-004 Augment Effect of a Combined Treatment of Statin and Angiotensin 2 Receptor Blocker on Circulating Adiponectin in Coronary Artery Disease(OE01,Cardiovascular Pharmacology (Clinical) (H),Oral Presentation (English),The 73rd Annual Scientific Meeting
- FRS-058 Effect of Intensive Lipid-lowering Therapy on Telomere Erosion in Endothelial Progenitor Cells Obtained from Patients with Coronary Artery Disease(FRS12,New Approaches to Atherosclerosis Research (IHD),Featured Research Session (English),The 73rd
- PJ-558 Mortality and Incidence Rates of Myocardial Infarction among Japanese Hemodialysis Patients : Results from 2-year Follow-up Data of 1145 Patients(Preventive medicine/Epidemiology/Education(07)(H),Poster Session(Japanese),The 72nd Annual Scientific
- PJ-368 Does Low Grade Inflammation Increase Heart Rate? : Possible Mechanism for Association between Elevated Heart Rate and Cardiovascular Events(Preventive medicine/Epidemiology/Education(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Meetin
- PJ-163 Elevated C-Reactive Protein Level is Associated with Atrial Fibrillation: A Community-Based Cross-Sectional Study(Preventive medicine/Epidemiology/Education(05)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulat
- PJ-425 Enalapril Enhances the Efficacy of Antiarrhythmic Drugs in Patients with Paroxysmal Atrial Fibrillation and Ischemic Heart Disease(PJ072,Atrial/Supraventricular Arrhythmia (Clinical/Treatment) 2 (A),Poster Session (Japanese),The 73rd Annual Scienti
- PJ-424 Upstream Therapy with Antiarrhythmic Drugs and Statin Had a High Degree of Efficacy in Female Patients with Paroxysmal Atrial Fibrillation(PJ072,Atrial/Supraventricular Arrhythmia (Clinical/Treatment) 2 (A),Poster Session (Japanese),The 73rd Annual
- PJ-412 Different Pharmacological Action on the Dispersion of Ventricular Repolarization between Intravenous Nifekalant and Amiodarone Therapy(PJ070,Ventricular Arrhythmia (Clinical/Diagnosis/Treatment) 1 (A),Poster Session (Japanese),The 73rd Annual Scien
- PJ-019 Combination Therapy with Enalapril and Pravastatin on Antiarrhythmic Drugs in Patients with Paroxysmal Atrail Fibrillation(PJ003,Atrial/Supraventricular Arrhythmia (Clinical/Diagnosis) (A),Poster Session (Japanese),The 73rd Annual Scientific Meetin
- PJ-009 Relationship between the Efficacy of Bepridil Therapy and Plasma Concentration of Atrial Natriuretic Peptide in Patients with Paroxysmal Atrial Fibrillation(PJ002,Atrial/Supraventricular Arrhythmia (Clinical/Pathophysiology) (A),Poster Session (Jap
- PE-323 Usefulness of 320-Slice Multidetector Computed Tomography to Assess In-Stent Restenosis : Comparison with Quantitative Coronary Angiography and Intravascular Ultrasound(PE054,CT/MRI (New Technology) (I),Poster Session (English),The 73rd Annual Scie
- PE-060 Is Japanese Guideline of Antithrombotic Therapy Valid to Prevent Ischemic Stroke for Patients with Nonvalvular Paroxysmal Atrial Fibrillation?(PE010,Thromboembolism/Antithrombotic Therapy/Thrombolysis 1 (IHD),Poster Session (English),The 73rd Annua
- PE-056 CHADS2 Score is a Useful Scheme for Risk Stratification of Thromboembolism in Japanese Patients with Paroxysmal Atrial Fibrillation(PE010,Thromboembolism/Antithrombotic Therapy/Thrombolysis 1 (IHD),Poster Session (English),The 73rd Annual Scientifi
- A randomized study on the efficacy of intravenous cibenzoline and pilsicainide administered prior to electrical cardioversion in patients with lone paroxysmal and persistent atrial fibrillation
- PJ-590 Relationship between heart failure and plasma concentrations of atrial naturiuretic peptide in patients with paroxysmal atrial fibrillation and diabetes mellitus(Arrhythmia, diagnosis/Pathophysiology/EPS(10)(A),Poster Session(Japanese),The 72nd Ann
- PJ-404 Efficacy of antiarrhythmic drugs therapy in preventing AF recurrence and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation(Arrhythmia, therapy(25)(A),Poster Session(Japanese),The 72nd Annual Scientific
- PE-262 Combination therapy with Bepridil and Enarapril prevents the development of atrial structural remodeling in patients with paroxysmal atrial fibrillation(Arrhythmia, therapy(13)(A),Poster Session(English),The 72nd Annual Scientific Meeting of the Ja
- PE-261 Efficacy of combination therapy with Enalapril on antiarrhythmic drugs in patients with atrial fibrillation ; relationship to the circadian variation of onset.(Arrhythmia, therapy(13)(A),Poster Session(English),The 72nd Annual Scientific Meeting of
- PE-145 Long-term cardiovascular prognosis in patients with paroxysmal atrial fibrillation ; Comparison between the groups with and without underlying structural heart disease(Arrhythmia, therapy(12)(A),Poster Session(English),The 72nd Annual Scientific Me
- Long-term Efficacy of Combination Therapy with Anti-arrhythmic Agents and Pravastatin in Patients with Paroxysmal Atrial Fibrillation
- PJ-292 Relationship between Long-term Cardiovascular Prognosis and Efficacy of Antiarrhythmic Drugs Therapy in Patients with Paroxysmal Atrial Fibrillation and Diabetes Mellitus(Arrhythmia, therapy-19, The 71st Annual Scientific Meeting of the Japanese Ci
- PJ-290 Efficacy of Intravenous Cibenzoline and Pilsicainide Administered Prior to Electrical Cardioversion in Patients with Lone and Persistent Paroxysmal Atrial Fibrillation(Arrhythmia, therapy-19, The 71st Annual Scientific Meeting of the Japanese Circu
- PJ-197 The Efficacy of Antiarrhythmic Drugs Therapy (Bepridil, Pilsicainide, Flecainide) with Regard to Structural Remodeling in Patients with Paroxysmal Atrial Fibrillation(Arrhythmia, diagnosis/pathophysiology/EPS-11, The 71st Annual Scientific Meeting
- PJ-196 The Combination Therapy with Amiodarone and Enalapril in patients with Paroxysmal Atrial Fibrillation Prevents the Development of Structural Remodeling(Arrhythmia, diagnosis/pathophysiology/EPS-11, The 71st Annual Scientific Meeting of the Japanese
- OJ-186 The Combination Therapy with Pravastatin and Enarapril Enhances the Efficacy of Antiarrhythmic Drugs in Preventing Recurrence of Paroxysmal Atrial Fibrillation(Arrhythmia, therapy-08, The 71st Annual Scientific Meeting of the Japanese Circulation S
- FRS-077 Genetic Analysis of KCR1 Gene in Japanese LQTS Patients(Arrhythmia (basic), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-813 Impact of Speckle Tracking Echocardiography on Evaluation of Myocardial Fibrosis in Hypertrophic Cardiomyopathy : Comparison with Study by Cardiovascular Magnetic Resonance(PJ136,Echo/Doppler (Others) 1 (I),Poster Session (Japanese),The 73rd Annual
- PJ-433 Impact of the HERG Channel Activator "Malltoxin" on Type 2 LQTS Related Mutant Channel(PJ073,Arrhythmia, Others (Basic) 1 (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OE-022 Impact of Troponin-Gene Mutations on Occurrence of Atrial Fibrillation and Development of Left Atrial Dilatation in Hypertrophic Cardiomyopathy(OE04,Cardiomyopathy/Hypertrophy (Clinical) (M),Oral Presentation (English),The 73rd Annual Scientific Me
- OE-019 Comparison of Phenotype of Hypertrophic Cardiomyopathy Associated with a Calcium Regulating Gene and a Sarcomere Gene(OE04,Cardiomyopathy/Hypertrophy (Clinical) (M),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circ
- OE-007 Transient Overexpression of Heme Oxygenase-1 Promotes Cardioprotection in Ischemic Myocardial Injury through Antioxidative Stress and -apoptotic Activities(OE02,ACS/AMI (Basic) (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting of
- 5 Impact of Combined Risk Factors on Reduction of Repolarization Reserve Associated with Drug-induced Abnormal QT Prolongation and Torsade de Pointes(Proarrhythmic Risk of Drugs and Their Evaluation,Symposium 7 (SY-07) (I),The 73rd Annual Scientific Meeti
- PJ-632 Association between Atrial Fibrillation and Left Atrial Diameter in Genotyped Populations of Hypertrophic Cardiomyopathy : Results from a Longitudinal Study(Cardiomyopathy, basic / clinical(06)(M),Poster Session(Japanese),The 72nd Annual Scientific
- PJ-564 Transient Overexpression of Heme Oxygenage-1 Promotes Tolerance of Transplanted Mesenchymal Stem Cells to Oxidative Stress(Regeneration (angiogenesis/myocardial regeneration)(05)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the
- PJ-202 Co-expression with Trafficking-competent KvLQT1 Selectively Rescues HERG LQT2 Mutations(Arrhythmia, basic(05)(A),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PE-074 Impact of Left Ventricular Systolic Dysfunction on QT Dispersion and Associated Fatal Arrhythmia in Hypertrophic Cardiomyopathy(ECG/Body surface potential mapping/Holter(03)(A),Poster Session(English),The 72nd Annual Scientific Meeting of the Japan
- OE-126 Angiotensin-Converting Enzyme D Allele is a Modifier Causing Left Ventricular Systolic Dysfunction in Genotyped Hypertrophic Cardiomyopathy : Results from Longitudinal Study(Heart failure, clinical(02)(M),Oral Presentation(English),The 72nd Annual
- FRS-035 Impact of Elevated Matrix Metalloproteinase-2 on Prognosis in Hypertrophic Cardiomyopathy with Sarcomere Gene Mutations(Molecular Determinants for the Development of Cardiomyopathy(M),Featured Research Session,The 72nd Annual Scientific Meeting of
- FRS-034 Impact of Anglotensin II Type 1 Receptor A/C1166 Gene Ploymorphism on the Onset of Atrial Fibrillation in Genotyped Hypertrophic Cardiomyopathy(Molecular Determinants for the Development of Cardiomyopathy(M),Featured Research Session,The 72nd Annu
- 2 Impact of Missense Mutations in Cardiac Ryanodine Receptor Gene as a Cause of Hypertrophic Cardiomyopathy : A New Insight From Ca Handling(Symposium 10 (SY-10) (M) Update in Cardiomyopathy : Novel Approaches ; Novel Targets,Special Program,The 72nd Annu
- 1 Prevalence of Long QT Syndrome and Frequencies of Gene Mutation Carriers in Japanese Children : an Epidemiological and Genetic Study(Plenary Session 4 (PL-4) (A) New Scientific Approaches to QT Prolongation,Special Program,The 72nd Annual Scientific Mee
- PJ-524 Extent and Localization of Myocardial Fibrosis in Hypertrophic Cardiomyopathy Associated with Sarcomere Protein Gene Mutation : Study by Magnetic Resonance Imaging(MRI/MRA-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-558 Prevalence of Long QT Syndrome and Frequencies of Gene Mutation Carriers in Japanese Children(Preventive medicine/Epidemiology/Education-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-240 Dilated-Phase Hypertrophic Cardiomyopathy Show More Severe Heart Failure Compared with Idiopathic Dilated Cardiomyopathy in Matched Symptomatic and Echocardiographic Settings(Heart failure, clinical-06, The 71st Annual Scientific Meeting of the Jap
- Clinical Profiles, Efficacy of Antiarrhythmic Drug Therapy, and Cardiovascular Prognosis in Patients With First Detected Paroxysmal Atrial Fibrillation
- Efficacy of Amiodarone for Preventing the Recurrence of Symptomatic Paroxysmal and Persistent Atrial Fibrillation After Cardioversion
- Efficacy of Long-term Flecainide Therapy in Patients with Paroxysmal Atrial Fibrillation : Analysis Based on Time of Onset
- PE-191 Specle-Tracking Radial and Transverse Displacements (STRTD) to Quantify Prolonged Diastolic Dyssynchrony in Myocardial Ischemia after Exercise Test(Echo/Doppler(06)(I),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circu
- PJ-317 CKD is Associated with Impairment of Arterial Elastic Property Independently of Conventional Atherosclerotic Risk Factors in the General Population(PJ054,Kidney/Renal Circulation/CKD 3 (H),Poster Session (Japanese),The 73rd Annual Scientific Meetin
- OE-417 Association between Oxidative DNA Damage and Telomere Shortening in Endothelial Progenitor Cells in Metabolic Syndrome Patients with Coronary Artery Disease(Atherosclerosis, clinical(02)(IHD),Oral Presentation(English),The 72nd Annual Scientific Me
- PJ-443 Inhibitory Effect of Low Dose Pioglitazone on the In-stent Restenosis in Patients with Acute Myocardial Infarction and Type 2 Diabetes(Acute myocardial infarction, clinical (diagnosis/treatment)-9 (IHD) PJ75,Poster Session (Japanese),The 70th Anniv
- PJ-603 Enhanced Asymmetric Dimethylarginine Synthesis in the Atrium of a Canine Atrial Fibrillation Model : A Possible Role in Endocardial Remodeling(Arrhythmia, basic-5 (A) PJ101,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of
- PJ-208 Left Ventricular Dyssynchrony by Tissue Doppler Echocardiography as a Predictor of Prognosis after Cardiac Resynchronization Therapy for Advanced Heart Failure(Heart failure, clinical-15 (M) PJ35,Poster Session (Japanese),The 70th Anniversary Annua
- OJ-354 Sinus Venosa Region as an Anatomical and Not Functional Obstacle in Isthmus-dependent Atrial Flutter(Arrhythmia, diagnosis/pathophysiology/EPS-4 (A) OJ59,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Ci
- Randomized Crossover Study of the Long-Term Effects of Pilsicainide and Cibenzoline in Preventing Recurrence of Symptomatic Paroxysmal Atrial Fibrillation : Influence of the Duration of Arrhythmia Before Therapy(Clinical Investigation)
- OJ-062 Elevated Plasma Level of Asymmetrical Dimethylarginine in Patients with Atrial Fibrillation : Possible Role for Cardiovascular Events(Arrhythmia, diagnosis/pathophysiology/EPS-3 (A) OJ11,Oral Presentation (Japanese),The 70th Anniversary Annual Scie
- Prospective Comparative Study of Intravenous Cibenzoline and Disopyramide Therapy in the Treatment of Paroxysmal Atrial Fibrillation After Cardiovascular Surgery
- Antithrombotic Therapy According to the Guidelines Issued by the Japanese Circulation Society in Patients with Nonvalvular Paroxysmal Atrial Fibrillation without Thromboembolic Risk Factors
- PJ-653 The Relationship between Long-term Preventive Effect of Antiarrhythmic Drug Therapy and Symptomatic Thromboembolism in Patients with Lone Paroxysmal Atrial Fibrillation(Cerebrovascular circulation/Stroke-3 (H) PJ110,Poster Session (Japanese),The 70
- PJ-312 Different Efficacy of Combination Therapy with Antiarrhythmic Drugs and Enalapril between the Patients Groups with and without Underlying Heart Disease(Arrhythmia, therapy-14 (A) PJ53,Poster Session (Japanese),The 70th Anniversary Annual Scientific
- PE-021 The Combination Therapy with Antiarrhythmic Drugs and Pravastatin in Patients with Lone Atrial Fibrillation Prevents the Development of Structural Remodeling(Arrhythmia, diagnosis/pathophysiology/EPS-6 (A) PE4,Poster Session (English),The 70th Anni
- OJ-118 Long-term Prognosis of Antithrombotic Therapy According to Guideline Recommended by Japanese Circulation Society in Patients with non-valvular Paroxysmal Atrial Fibrillation(Thromboembolism/Antithrombotic therapy/Thrombolysis-2 (H) OJ20,Oral Presen
- Angiotensin Converting Enzyme Inhibitor Enhances Efficacy of Amiodarone and not Class-I Antiarrhythmic Drug in Preventing Recurrence of Paroxysmal Atrial Fibrillation(Arrhythmia, Pharmacological Therapy 2 (A), The 69th Annual Scientific Meeting of the Jap
- Relationship between the Response to Antiarrhythmic Drug Therapy and the Development of Structural Remodeling in Patients with Paroxysmal Atrial Fibrillation(Arrhythmia, Diagnosis/Pathophysiology/EPS 3 (A), The 69th Annual Scientific Meeting of the Japane
- Pravastatin Enhances the Efficacy of Class I Antiarrhythmic Agents in Patients with Paroxysmal Atrial Fibrillation and Hyperlipidemia(Arrhythmia, Non-pharmacological Therapy 8 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Efficacy of Antiarrhythmic Therapy in Preventing Recurrence of Paroxysmal Atrial Fibrillation not Showing Any Circadian Variation in the Onset(Arrhythmia, Pharmacological Therapy 1 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Societ
- Long-Term Prognosis of Patients With Paroxysmal Atrial Fibrillation Depends on Their Response to Antiarrhythmic Therapy
- Impact of Renin-Angiotensin System Polymorphisms on Development of Systolic Dysfunction in Hypertrophic Cardiomyopathy : Evidence From a Study of Genotyped Patients
- Relationship Between the Long-Term Preventive Effect of Combined Treatment With Antiarrhythmic Drugs Plus Angiotensin-Converting Enzyme Inhibitors and Circadian Variation in the Onset of Paroxysmal Atrial Fibrillation
- Unusual biatrial thrombus in mitral stenosis
- Long-Term Efficacy of Amiodarone Therapy for the Prevention of Recurrence of Paroxysmal Atrial Fibrillation : Analysis Based on Patient Characteristics
- PJ-466 The Long-term Cardiovascular Prognosis of the Patients with Paroxysmal Atrial Fibrillation Depends on Their Response to Antiarrhythmic Drugs Therapy(Arrhythmia, therapy-17 (A) PJ79,Poster Session (Japanese),The 70th Anniversary Annual Scientific Me
- Gene and Protein Expression Analysis of Mesenchymal Stem Cells Derived From Rat Adipose Tissue and Bone Marrow
- Time in the Therapeutic Range During Warfarin Therapy in Japanese Patients With Non-Valvular Atrial Fibrillation : A Multicenter Study of Its Status and Influential Factors
- Combination Therapy With Amiodarone and Enalapril in Patients With Paroxysmal Atrial Fibrillation Prevents the Development of Structural Atrial Remodeling
- Tuberculous Retropharyngeal Abscess Associated with Spinal Tuberculosis Well Controlled by Fine-needle Aspiration and Anti-tuberculous Chemotherapy
- Practical Issue of Pharmacological Management in Paroxysmal Atrial Fibrillation Patients Treated with Anticoagulant Therapy
- Long-term Efficacy of Upstream Therapy With Lipophilic or Hydrophilic Statins on Antiarrhythmic Drugs in Patients With Paroxysmal Atrial Fibrillation Comparison Between Atorvastatin and Pravastatin:Comparison Between Atorvastatin and Pravastatin
- Relationship Between CHADS2 Score and Efficacy of Antiarrhythmic Drug Therapy in Patients With Paroxysmal Atrial Fibrillation
- Long-Term Efficacy of Upstream Therapy Using Angiotensin-Converting Enzyme Inhibitors and Statins in Combination With Antiarrhythmic Agents for the Treatment of Paroxysmal Atrial Fibrillation